Overview

A Drug-drug Interaction Study to Investigate the Pharmacokinetic Interactions Between CKD-508, Midazolam, and Rosuvastatin in Healthy Adult Male Participants

Status:
NOT_YET_RECRUITING

Trial end date:
2025-08-16

Target enrollment:

Participant gender:

Summary

Phase 1, open-label, non-randomized, three-treatment, one-sequence interaction study to evaluate the PK interactions between CKD-508, midazolam, and rosuvastatin in healthy adult male participants

Phase:

PHASE1

Details

Lead Sponsor:

Chong Kun Dang Pharmaceutical

Treatments:

Midazolam
Rosuvastatin Calcium